CoChat

Statin-Associated Myopathy with Normal Creatine Kinase Levels

Phillips, Paul S., Haas, Richard H., Bannykh, Sergei, Hathaway, Stephanie, Gray, Nancy L., Kimura, Bruce J., Vladutiu, Georgirene D., England, John D.F., and the Scripps Mercy Clinical Research Center* · 2002 · Annals of Internal Medicine

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Background Muscle symptoms in patients who are treated with statins and have normal creatine kinase levels are not well understood. Objective To report biopsy-confirmed myopathy and normal creatine kinase levels associated with statin use. Design Case reports from preliminary analysis of an ongoing clinical trial. Setting Clinical research center in a community hospital. Patients Four patients with muscle symptoms that developed during statin therapy and reversed during placebo use. Measurements 1) Patients' ability to identify blinded statin therapy and 2) standard measures of functional capacity and muscle strength. Results All four patients repeatedly distinguished blinded statin therapy from placebo. Strength testing confirmed weakness during statin therapy that reversed during placebo use. Muscle biopsies showed evidence of mitochondrial dysfunction, including abnormally increased lipid stores, fibers that did not stain for cytochrome oxidase activity, and ragged red fibers. These findings reversed in the three patients who had repeated biopsy when they were not receiving statins. Creatine kinase levels were normal in all four patients despite the presence of significant myopathy. Conclusion Some patients who develop muscle symptoms while receiving statin therapy have demonstrable weakness and histopathologic findings of myopathy despite normal serum creatine kinase levels.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-137-7-200210010-00009

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 2

  1. 1994, Lancet, 344, 1383
  2. 10.1345/aph.19242 · doi:10.1345/aph.19242 · Paper page

Cited by

See all 622

Metadata

Authors
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center*
Affiliations
Scripps Mercy Hospital (US)
Venue
Annals of Internal Medicine
Published
2002-10-01
Volume
137
Issue
7
Pages
581-585
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2130873593
Cited by
565
References
21
Citations by year
2026: 4 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 10 · 2021: 11 · 2020: 18 · 2019: 21 · 2018: 16 · 2017: 12 · 2016: 26 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 26
FWCI
35.88
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Keywords
statin-induced myopathy, statins, muscle weakness, mitochondrial dysfunction, ragged-red fibers, cytochrome c oxidase, muscle biopsy, drug-induced myopathy
MeSH terms
Atorvastatin, Aged, Anticholesteremic Agents, Biopsy, Creatine Kinase, Double-Blind Method, Female, Heptanoic Acids, Humans, Lovastatin, Male, Muscular Diseases, Pain, Pyrroles, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Simvastatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statin-Associated Myopathy with Normal Creatine Kinase Levels. https://app.cochat.ai/papers/10.7326/0003-4819-137-7-200210010-00009
The paper
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center*. (2002). Statin-Associated Myopathy with Normal Creatine Kinase Levels. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-7-200210010-00009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.